Syndemic due to COVID-19 and type 2 diabetes mellitus: a dangerous interaction

Authors

  • Franklin Rómulo Aguilar-Gamboa Hospital Regional Lambayeque. Laboratorio de Inmunología – Virología. Dirección de Investigación. Grupo de investigación en Inmunología y Virología del Norte. Lambayeque. https://orcid.org/0000-0003-1943-5613
  • Danny Omar Suclupe-Campos Universidad Nacional Pedro Ruiz Gallo. Facultad de Ciencias Biológicas. Departamento de Microbiología. Grupo de investigación en Inmunología y Virología del Norte. Lambayeque. https://orcid.org/0000-0003-4930-3689
  • Jorge Arturo Vega-Fernández Universidad Nacional Pedro Ruiz Gallo. Facultad de Ciencias Biológicas. Departamento de Microbiología. Grupo de investigación en Inmunología y Virología del Norte. Lambayeque. https://orcid.org/0000-0003-0073-033X

Keywords:

COVID-19, CORONAVIRUS INFECTIONS, DIABETES MELLITUS, SARS VIRUS, SYNDEMIC

Abstract

Background: type 2 diabetes mellitus (T2DM) is considered an important risk factor for mortality in patients infected by respiratory viruses, included SARS-CoV-2. The interaction of both diseases can be considered as a syndemic.

Objective: to describe the pathophysiological characteristics and the molecular bases that hold the interaction of T2DM and COVID-19 as a part of a syndemic.

Methods: a review of the scientific literature on the topic was carried out. The following bibliographic and date bases were consulted: MEDLINE, PubMed, SciELO and LILACS. In the search and information analysis the following terms were used: COVID-19, SARS-CoV-2, type 2 diabetes mellitus and infection. There were no restrictions on language.

Results: the coincidence of T2DM and COVID-19 is not only a comorbidity in affected patients; there is a scientific support for their interaction. This is more evident in some contexts, due to the social aspect and the socioeconomic conditions of the affected people. The high levels of glycemia may increase the expression of the receptors that make possible the entrance of SARS-CoV-2 to cells. Diabetic patients have an innate compromised immune response. Diabetes and hyperglycemia are risk factors for a worse prognosis of the progress of COVID-19.

Conclusions: in the scientific literature there are evidences that hold the interaction between T2DM and COVID-19 as part of a syndemic.

Downloads

Download data is not yet available.

Author Biographies

Franklin Rómulo Aguilar-Gamboa, Hospital Regional Lambayeque. Laboratorio de Inmunología – Virología. Dirección de Investigación. Grupo de investigación en Inmunología y Virología del Norte. Lambayeque.

Biólogo

Danny Omar Suclupe-Campos, Universidad Nacional Pedro Ruiz Gallo. Facultad de Ciencias Biológicas. Departamento de Microbiología. Grupo de investigación en Inmunología y Virología del Norte. Lambayeque.

Biólogo

Jorge Arturo Vega-Fernández, Universidad Nacional Pedro Ruiz Gallo. Facultad de Ciencias Biológicas. Departamento de Microbiología. Grupo de investigación en Inmunología y Virología del Norte. Lambayeque.

Biólogo

References

Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab. Syndr. Clin. Res. Rev. [revista en internet]. 2020 [citado 21 de febrero 2021]; 14(3): 211–2. Disponible en: https://dx.doi.org/10.1016%2Fj.dsx.2020.03.002.

Pugliese G, Vitale M, Resi V, Orsi E. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)? Acta Diabetol. [revista en internet]. 2020 [citado 21 de febrero 2021]; 57(11): 1275–85. Disponible en: https://dx.doi.org/10.1007%2Fs00592-020-01586-6.

Horton R. Offline: COVID-19 is not a pandemic. Lancet [revista en internet]. 2020 [citado 21 de febrero 2021]; 396(10255): 874. Disponible en: https://doi.org/10.1016/S0140-6736(20)32000-6.

Farne H, Singanayagam A. Why asthma might surprisingly protect against poor outcomes in COVID-19. Eur. Respir. J. [revista en internet]. 2020 [citado 21 de febrero 2021]; 2003045. Disponible en: https://doi.org/10.1183/13993003.03045-2020.

Singer M. Introduction to syndemics : a critical systems approach to public and community health [Internet]. San Francisco, CA: Jossey-Bass; 2009. Disponible en: http://site.ebrary.com/id/10310638.

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA [revista en internet]. 2020 [citado 21 de febrero 2021]; 323(13): 1239. Disponible en: https://doi.org/10.1001/jama.2020.2648.

WHO (OMS). Diabetes [en línea]. Luxemburgo: OMS; 2020 [citado 21 de febrero 2021]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/diabetes.

Hawkins RB, Charles EJ, Mehaffey JH. Socio-economic status and COVID-19–related cases and fatalities. Public. Health [revista en internet]. 2020 [citado 21 de febrero 2021]; 189: 129–34. Disponible en: https://doi.org/10.1016/j.puhe.2020.09.016.

Wu A, Mihaylova VT, Landry ML, Foxman EF. Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study. The Lancet Microbe [revista en internet]. 2020 [citado 21 de febrero 2021]; 1(6): e254–62. Disponible en: https://doi.org/10.1016/S2666-5247(20)30114-2.

Shekhar S, Wurth R, Kamilaris CDC, Eisenhofer G, Barrera FJ, Hajdenberg M, et al. Endocrine Conditions and COVID-19. Horm. Metab. Res. [revista en internet]. 2020 [citado 21 de febrero 2021]; 52(07): 471–84. Disponible en: https://dx.doi.org/10.1055%2Fa-1172-1352.

Alvarado-Vasquez N. Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19? Med Hypotheses [revista en internet]. 2020 [citado 21 de febrero 2021]; 146: 110378. Disponible en: https://doi.org/10.1016/j.mehy.2020.110378.

Yu B, Li C, Sun Y, Wang DW. Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes. Cell. Metab. [revista en internet]. 2020 [citado 21 de febrero 2021]; 33(1): 65-77. Disponible en: https://doi.org/10.1016/j.cmet.2020.11.014.

Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: The conundrum. Diabetes Res. Clin. Pract. [revista en internet]. 2020 [citado 21 de febrero 2021]; 162: 108132. Disponible en: https://dx.doi.org/10.1016%2Fj.diabres.2020.108132.

Erener S. Diabetes, infection risk and COVID-19. Mol. Metab. [revista en internet]. 2020 [citado 21 de febrero 2021]; 39: 101044. Disponible en: https://dx.doi.org/10.1016%2Fj.molmet.2020.101044.

Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol. Med. Microbiol. [revista en internet]. 1999 [citado 21 de febrero 2021]; 26(3–4): 259–65. Disponible en: https://doi.org/10.1111/j.1574-695x.1999.tb01397.x.

Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nat. Rev. Endocrinol. [revista en internet]. 2020 [citado 21 de febrero 2021]; 16(6): 297–8. Disponible en: https://doi.org/10.1038/s41574-020-0353-9.

Sachdeva S, Desai R, Gupta U, Prakash A, Jain A, Aggarwal A. Admission Hyperglycemia in Non-diabetics Predicts Mortality and Disease Severity in COVID-19: a Pooled Analysis and Meta-summary of Literature. SN Compr. Clin. Med. [revista en internet]. 2020 [citado 21 de febrero 2021]; 2(11): 2161–6. Disponible en: https://doi.org/10.1007/s42399-020-00575-8.

Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia [revista en internet]. 2020 [citado 21 de febrero 2021]; 63(8): 1500–15. Disponible en: https://doi.org/10.1007/s00125-020-05180-x.

Singh AK, Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract [revista en internet]. 2020 [citado 21 de febrero 2021]; 167: 108382. Disponible en: https://dx.doi.org/10.1016%2Fj.diabres.2020.108382.

Yang JK, Feng Y, Yuan MY, Yuan SY, Fu HJ, Wu BY, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet. Med. [revista en internet]. 2006 [citado 21 de febrero 2021]; 23(6): 623–8. Disponible en: https://doi.org/10.1111/j.1464-5491.2006.01861.x.

Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C Assay Into Estimated Average Glucose Values. Diabetes Care [revista en internet]. 2008 [citado 21 de febrero 2021]; 31(8): 1473–8. Disponible en: https://doi.org/10.2337/dc08-0545.

Liao W-I, Wang J-C, Chang W-C, Hsu C-W, Chu C-M, Tsai S-H. Usefulness of Glycemic Gap to Predict ICU Mortality in Critically Ill Patients With Diabetes. Medicine (Baltimore) [revista en internet]. 2015 [citado 21 de febrero 2021]; 94(36): e1525. Disponible en: https://doi.org/10.1097/md.0000000000001525.

Su Y-W, Hsu C-Y, Guo Y-W, Chen H-S. Usefulness of the plasma glucose concentration-to-HbA1c ratio in predicting clinical outcomes during acute illness with extreme hyperglycaemia. Diabetes Metab. [revista en internet]. 2017 [citado 21 de febrero 2021]; 43(1): 40–7. Disponible en: https://doi.org/10.1016/j.diabet.2016.07.036.

Chang M-W, Huang C-Y, Liu H-T, Chen Y-C, Hsieh C-H. Stress-Induced and Diabetic Hyperglycemia Associated with Higher Mortality among Intensive Care Unit Trauma Patients: Cross-Sectional Analysis of the Propensity Score-Matched Population. Int. J. Environ. Res. Public. Health [revista en internet]. 2018 [citado 21 de febrero 2021]; 15(5): 992. Disponible en: https://dx.doi.org/10.3390%2Fijerph15050992.

Ceriello A, Russo P d., Amstad P, Cerutti P. High Glucose Induces Antioxidant Enzymes in Human Endothelial Cells in Culture: Evidence Linking Hyperglycemia and Oxidative Stress. Diabetes [revista en internet]. 1996 [citado 21 de febrero 2021]; 45(4): 471–7. Disponible en: https://doi.org/10.2337/diab.45.4.471.

Ceriello A. Acute hyperglycaemia: a ‘new’ risk factor during myocardial infarction. Eur. Heart. J. [revista en internet]. 2005 [citado 21 de febrero 2021]; 26(4): 328–31. Disponible en: https://doi.org/10.1093/eurheartj/ehi049.

Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol [revista en internet]. 2020 [citado 21 de febrero 2021]; 146(1): 110–8. Disponible en: https://doi.org/10.1016/j.jaci.2020.04.006.

Müller JA, Groß R, Conzelmann C, Krüger J, Koepke L, Steinhart J, et al. SARS-CoV-2 infects cells of the human exocrine and endocrine pancreas and interferes with beta-cell function. Res. Sq. [revista en internet]. 2020 [citado 21 de febrero 2021]; 2020(2020). Disponible en: https://doi.org/10.21203/rs.3.rs-96076/v1.

Ceriello A, De Nigris V, Prattichizzo F. Why is hyperglycemia worsening COVID‐19 and its prognosis? Diabetes, Obes Metab [revista en internet]. 2020 [citado 21 de febrero 2021]; 22(10): 1951–2. Disponible en: https://dx.doi.org/10.1111%2Fdom.14098.

Deisl C, Simonin A, Anderegg M, Albano G, Kovacs G, Ackermann D, et al. Sodium/hydrogen exchanger NHA2 is critical for insulin secretion in-cells. Proc Natl Acad Sci [revista en internet]. 2013 [citado 21 de febrero 2021]; 110(24): 10004–9. Disponible en: https://doi.org/10.1073/pnas.1220009110.

Cure E, Cumhur Cure M. COVID-19 may affect the endocrine pancreas by activating Na+/H+ exchanger 2 and increasing lactate levels. J Endocrinol. Invest. [revista en internet]. 2020 [citado 21 de febrero 2021]; 43(8): 1167–8. Disponible en: https://doi.org/10.1007/s40618-020-01307-4.

Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest [revista en internet]. 2020 [citado 21 de febrero 2021]; 43(7): 1027–31. Disponible en: https://doi.org/10.1007/s40618-020-01276-8%0A.

Downloads

Published

2021-05-11

How to Cite

1.
Aguilar-Gamboa FR, Suclupe-Campos DO, Vega-Fernández JA. Syndemic due to COVID-19 and type 2 diabetes mellitus: a dangerous interaction. Rev. electron. Zoilo [Internet]. 2021 May 11 [cited 2025 Sep. 20];46(3):e2742. Available from: https://revzoilomarinello.sld.cu/index.php/zmv/article/view/2742

Issue

Vol. 46 No. 3 (2021): May-June

Section

Review articles

License

This journal provides free and immediate access to its content under the principle that making research freely available to the public supports a greater exchange of global knowledge. This means that the authors transfer the copyright to the journal, so that copies and distribution of the contents can be made by any means, as long as the authors' acknowledgment is maintained. These terms are a reflection that the journal assumes copyright under Creative Commons licenses, specifically under a Creative Commons Attribution 4.0 International license.

Registration and submission of articles to the journal is free. The processing, including review, editing and publication, is completely free of charge.